Jackson Square Capital’s NuVasive, Inc. NUVA Stock Holding History

Jackson Square Capital’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-333	Closed	-$16K	–	343
2020 Q3	$16K	Hold	333	–	–	0.01%	238
2020 Q2	$19K	Hold	333	–	–	0.01%	203
2020 Q1	$17K	Hold	333	–	–	0.01%	180
2019 Q4	$26K	Buy	+333	New	+$23.5K	0.02%	194

Other funds holding NUVA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Jackson Square Capital's NUVA Position: Q4 2020 in Review

Jackson Square Capital sold out of NuVasive, Inc. (NUVA) in Q4 2020, closing a stake of 333 shares — an estimated $16K sold.

Jackson Square Capital first reported a position in NUVA in Q4 2019 and held it in 4 quarters. The position peaked at $26K in Q4 2019. 280 funds tracked by Wall St. Rank hold NUVA as of Q4 2020.

Jackson Square Capital reported no remaining NuVasive, Inc. position as of Q4 2020 after selling out during the quarter.
Jackson Square Capital sold 333 NuVasive, Inc. shares in Q4 2020, an estimated $16K.
Jackson Square Capital first reported a position in NuVasive, Inc. in Q4 2019 and held it in 4 quarters.
Jackson Square Capital's NuVasive, Inc. position peaked at $26K in Q4 2019.
280 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2020.

Based on Jackson Square Capital's 13F filing for Q4 2020, filed 5 Mar 2021.